Use of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Geriatric Ischemic Stroke Patients: Are the Rates Right?

Use of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Geriatric Ischemic Stroke Patients: Are the Rates Right?

BackgroundOur objective is to estimate the effects associated with higher rates of renin‐angiotensin system antagonists, angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers (ACEI/ARBs), in secondary prevention for geriatric (aged >65 years) patients with new ischemic stroke...

Full description

Bibliographic Details
Main Authors: John M. Brooks, Cole G. Chapman, Manish Suneja, Mary C. Schroeder, Michelle A. Fravel, Kathleen M. Schneider, June Wilwert, Yi‐Jhen Li, Elizabeth A. Chrischilles, Douglas W. Brenton, Marian Brenton, Jennifer Robinson
Format: Article
Language:English
Published: Wiley 2018-06-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
angiotensin receptor
chronic kidney disease
instrumental variables
ischemic stroke
renin angiotensin system
secondary prevention
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.118.009137

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.118.009137

Similar Items